Fibrosis is a characteristic of skin conditions such as lipedema and cellulite that affects healthy skin function and can cause life-changing malformations, pain and mental strain for millions of patients. Aliform B.V. developed a groundbreaking minimally invasive surgical technology for the treatment of skin fibrosis. This technology is applicable to both lipedema and cellulite and improves the safety and effectiveness of treatment, improves recovery and reduces costs for patients. In order to realize this technology and create a positive impact, Aliform B.V., Medace B.V. and DEMCON have founded the SKINERGY project. The project draws on the complementary medical device expertise of the partners on the Brightlands Maastricht Health Campus to improve patient care, create qualified jobs, create equal opportunities, foster innovation and build collaboration in the medical sector in the South of the Netherlands.